Supplemental Figure 2 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
Key Points
Key points are not available for this paper at this time.
Abstract
Supplemental Figure 2: Gender-based comparison of Tumoral LTZ and E2 concentrations across the five-dose cohorts
AI에게 질문
Like
Bookmark
Share
View Full Paper
AI에게 질문
Like
Bookmark
Share
View Full Paper
Supplemental Figure 2 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas | Synapse